Kyle Rose
Stock Analyst at Canaccord Genuity
(3.37)
# 873
Out of 4,874 analysts
114
Total ratings
53.26%
Success rate
13.79%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $30.21 | -10.63% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $309.83 | +4.57% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $390.40 | +11.42% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $58.82 | +20.71% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $32.26 | +120.09% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.07 | +56.36% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.94 | +415.46% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $10.90 | +101.83% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $85.04 | +76.39% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $7.74 | +3,388.37% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $18.09 | +49.25% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.85 | +710.81% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $10.46 | +43.40% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $180.80 | -32.52% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $3.58 | +11.73% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.67 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $91.74 | +36.25% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $30.21
Upside: -10.63%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $309.83
Upside: +4.57%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $390.40
Upside: +11.42%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $58.82
Upside: +20.71%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $32.26
Upside: +120.09%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.07
Upside: +56.36%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.94
Upside: +415.46%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $10.90
Upside: +101.83%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $85.04
Upside: +76.39%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $7.74
Upside: +3,388.37%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $18.09
Upside: +49.25%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.85
Upside: +710.81%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $10.46
Upside: +43.40%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $180.80
Upside: -32.52%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $3.58
Upside: +11.73%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $6.67
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $91.74
Upside: +36.25%